Evidence map›Paper›PMID 40353056›Full record

ArticleAging medicine (Milton (N.S.W))2025

Patchouli Ethanol Extract

Teguh Santoso, Astrid Feinisa Khairani, Muhammad Hasan Bashari, Julia Ramadhanti, Enny Rohmawati, Monika Pury Oktora, Hesti Lina Wiraswati

Abstract read
In one paragraph

Article in Aging medicine (Milton (N.S.W)), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Teguh SantosoGraduate School of Master Program in Anti-Aging and Aesthetic Medicine Faculty of Medicine, Universitas Padjadjaran Bandung West Java Indonesia.ORCID https://orcid.org/0009-0007-8809-3027
Astrid Feinisa KhairaniGraduate School of Master Program in Anti-Aging and Aesthetic Medicine Faculty of Medicine, Universitas Padjadjaran Bandung West Java Indonesia.ORCID https://orcid.org/0000-0001-7242-4791
Muhammad Hasan BashariGraduate School of Master Program in Anti-Aging and Aesthetic Medicine Faculty of Medicine, Universitas Padjadjaran Bandung West Java Indonesia.ORCID https://orcid.org/0000-0001-7298-0317
Julia RamadhantiGraduate School of Master Program in Anti-Aging and Aesthetic Medicine Faculty of Medicine, Universitas Padjadjaran Bandung West Java Indonesia.ORCID https://orcid.org/0000-0001-5921-7624
Enny RohmawatiGraduate School of Master Program in Anti-Aging and Aesthetic Medicine Faculty of Medicine, Universitas Padjadjaran Bandung West Java Indonesia.ORCID https://orcid.org/0000-0002-4232-3727
Monika Pury OktoraClinical Pharmacy and Pharmacology Department University Medical Center Groningen, University of Groningen Groningen the Netherlands.ORCID https://orcid.org/0000-0002-3116-787X
Hesti Lina WiraswatiGraduate School of Master Program in Anti-Aging and Aesthetic Medicine Faculty of Medicine, Universitas Padjadjaran Bandung West Java Indonesia.ORCID https://orcid.org/0000-0003-2462-6633

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This research aimed to investigate the potential of Methods: We treated 3T3-L1 cells induced by doxorubicin with PCEE and assessed them with antiaging markers such as Results: This study demonstrates that PCEE can inhibit ROS accumulation, decrease the expression level of the senescence-associated β-galactosidase (SA-β-gal) Conclusion: These studies reveal that PCEE is a promising antiaging agent. An in vivo approach should be conducted for further research.

Indexed as

3T3‐L1 cellsagingcellular senescencereactive oxygen speciestelomere

Identifiers

PMID40353056
PMCPMC12064996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.